ICL surgery is a vision correction procedure where a thin, biocompatible lens is implanted in the eye, between the iris and the natural lens, to correct refractive errors like nearsightedness, farsightedness, and astigmatism.

Ideal candidates are individuals aged 21 to 45 with stable vision, moderate to severe nearsightedness, and thin corneas or dry eyes that make them ineligible for LASIK or PRK.

Unlike LASIK, which reshapes the cornea, ICL involves implanting a lens inside the eye. It’s reversible and doesn’t remove any corneal tissue.

Recovery is quick, with most patients noticing improved vision within 24 hours. Normal activities can usually resume in a few days, although full stabilization of vision may take a few weeks.

No, the lens is designed to be undetectable. It stays in place without requiring maintenance or any sensation of its presence.

Yes, the ICL is removable and can be replaced if your prescription changes significantly or if you need a different vision correction in the future.

Yes, ICL surgery is FDA-approved and has a high success rate. Like any surgery, there are risks, including infection, increased eye pressure, or glare/halos, which will be discussed during your consultation.

The ICL is designed to last a lifetime, but it can be removed or replaced if needed due to changing vision or other eye conditions.

ICL surgery is usually an elective procedure and not covered by insurance. Costs vary depending on the lens type, with financing options often available.

Possible risks include dry eye, glare, halos, infection, or increased intraocular pressure. Severe complications are rare, and most side effects are temporary and manageable.